Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GPhC investigating committee members 'do not reflect sector'

Pharmacy law specialist David Reissner says the regulator’s fitness-to-practise decision-makers lack recent community pharmacy experience

Many of the individuals who decide whether a community pharmacist must undergo fitness-to-practise proceedings do not have recent experience in the sector, a law firm has highlighted.

Charles Russell Speechlys, which specialises in representing pharmacists in regulatory matters, said that, in the past, “most” of the members of the General Pharmaceutical Council (GPhC) investigating committee have not had “recent, let alone current” experience of working in a community pharmacy.

The firm’s senior healthcare partner David Reissner stressed that the “vast majority of complaints” considered by the committee concern “something that happens in community pharmacy”.

“Better efforts should be made to attract and appoint committee members who are more representative of the people whose cases they are considering,” Mr Reissner said in the law firm’s response to a GPhC consultation on draft guidance for the committee, seen by C+D last week (October 16).

The GPhC told C+D yesterday (October 20) that it will consider the response “alongside all other representations” to the consultation, which closed last month.

The government and “all health professional regulators” have considered issues around the “lay and professional balance” of regulatory committee membership “at length”, the GPhC stressed. “We have a robust and independent appointments process for [committee members] that supports good, independent decision-making,” it added.

Mr Reissner also used the consultation response to highlight that the GPhC had not included draft guidance on when this investigating committee should issue a warning. This could be a “proportionate way to dispose of a case” that was not serious enough to subject the registrant to the full fitness-to-practise process, he said.

“This [process] causes unnecessary cost to the [GPhC] and stress to the registrant and his or her family,” he added.

 


Do you think fitness-to-practise proceedings are fair?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007772

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel